The North Louisiana Economic Partnership (NLEP) welcomed U.S. Senator Bill Cassidy, M.D. (R-LA) to the former Dr. Reddy’s Laboratories facility on Line Avenue in Shreveport on May 9, 2025. The visit underscored the site’s potential to bolster domestic pharmaceutical manufacturing and stimulate economic growth in Northwest Louisiana.

During the tour, Senator Cassidy engaged with officials from NLEP and Louisiana Economic Development (LED), as well as Louisiana Senator Thomas Pressly and Caddo Parish Commissioner Ronald Cothran, to discuss strategies for attracting new ownership to the facility, aiming to resume medicine production. The facility, previously operated by Dr. Reddy’s Laboratories, is equipped to produce up to 4 billion tablets annually, presenting a significant opportunity for pharmaceutical companies seeking to expand or reshore manufacturing operations.

“Senator Cassidy has long been a champion for North Louisiana, and we deeply appreciate all he has done – and continues to do – for our region,” said Justyn Dixon, President and CEO of NLEP. “With the growing number of pharmaceutical companies announcing plans to reshore or expand manufacturing operations, we believe the Dr. Reddy’s site provides these companies the ideal speed-to-market opportunity. We appreciate the Senator taking the time to visit and engage directly to gain a deeper understanding of this valuable asset.”

Senator Cassidy emphasized the importance of domestic drug manufacturing, stating, “President Trump is doing his best to make the United States a place where businesses invest in. We need increased domestic manufacturing of drugs. I’m committed to the economic development of Northwest Louisiana, and bringing in full production facilities for drugs and other goods.”

The visit aligns with national efforts to enhance the resilience of the U.S. pharmaceutical supply chain. Recent expansion announcements by Johnson & Johnson, Eli Lilly, Gilead Sciences and others highlight the industry’s shift towards onshore manufacturing. NLEP is actively collaborating with stakeholders to position the Shreveport facility as a prime location for such investments.